Consequently, various markers of endothelial activation and inflammation, including vascular endothelial growth factor (VEGF), intercellular adhesion molecule-1 (ICAM-1), and monocyte chemoattractant protein-1 (MCP1), are elevated in patients and markers of inflammation are associated with cardiac disease progression in FD12–16. This evidence concerns the gene ICAM1 and heart disorder.